W.N. Spellacy

748 total citations
30 papers, 552 citations indexed

About

W.N. Spellacy is a scholar working on Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health and Reproductive Medicine. According to data from OpenAlex, W.N. Spellacy has authored 30 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Public Health, Environmental and Occupational Health and 10 papers in Reproductive Medicine. Recurrent topics in W.N. Spellacy's work include Ovarian function and disorders (10 papers), Reproductive Health and Contraception (7 papers) and Hormonal and reproductive studies (6 papers). W.N. Spellacy is often cited by papers focused on Ovarian function and disorders (10 papers), Reproductive Health and Contraception (7 papers) and Hormonal and reproductive studies (6 papers). W.N. Spellacy collaborates with scholars based in United States, Netherlands and Canada. W.N. Spellacy's co-authors include S.A. Birk, W.C. Buhi, Karen L. Carlson, Robert O. Fisch, F. C. Goetz, Craig S. Kalter, Hector Arango, William Cohen, James V. Fiorica and John C.M. Tsibris and has published in prestigious journals such as The Lancet, Diabetes and American Journal of Obstetrics and Gynecology.

In The Last Decade

W.N. Spellacy

29 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W.N. Spellacy United States 13 191 141 133 123 118 30 552
Josef Zander Germany 16 94 0.5× 157 1.1× 78 0.6× 56 0.5× 118 1.0× 50 788
Badri N. Saxena India 12 68 0.4× 125 0.9× 76 0.6× 98 0.8× 55 0.5× 17 427
S.C. MacLeod Canada 11 92 0.5× 242 1.7× 166 1.2× 240 2.0× 227 1.9× 24 696
RodneyP. Shearman Australia 14 92 0.5× 203 1.4× 79 0.6× 99 0.8× 185 1.6× 21 515
Apichart Chittacharoen Thailand 13 115 0.6× 102 0.7× 160 1.2× 175 1.4× 49 0.4× 58 558
M. Culliton Ireland 13 214 1.1× 170 1.2× 163 1.2× 115 0.9× 225 1.9× 29 672
Leo Mäkäräinen Finland 14 49 0.3× 321 2.3× 241 1.8× 144 1.2× 246 2.1× 22 653
Ayşe Kafkaslı Türkiye 16 47 0.2× 130 0.9× 195 1.5× 123 1.0× 110 0.9× 40 521
Erdoğan Aslan Türkiye 15 81 0.4× 161 1.1× 123 0.9× 49 0.4× 190 1.6× 33 615
CN Wijeyaratne Sri Lanka 12 196 1.0× 208 1.5× 87 0.7× 53 0.4× 286 2.4× 27 624

Countries citing papers authored by W.N. Spellacy

Since Specialization
Citations

This map shows the geographic impact of W.N. Spellacy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.N. Spellacy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.N. Spellacy more than expected).

Fields of papers citing papers by W.N. Spellacy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.N. Spellacy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.N. Spellacy. The network helps show where W.N. Spellacy may publish in the future.

Co-authorship network of co-authors of W.N. Spellacy

This figure shows the co-authorship network connecting the top 25 collaborators of W.N. Spellacy. A scholar is included among the top collaborators of W.N. Spellacy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.N. Spellacy. W.N. Spellacy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jazayeri, Allahyar, et al.. (2002). A prospective study of vaginal pH as a predictor of preterm delivery. The Journal of Maternal-Fetal & Neonatal Medicine. 11(1). 30–33. 9 indexed citations
2.
Kalter, Craig S., et al.. (1994). Sonographic diagnosis of a large umbilical cord pseudocyst.. Journal of Ultrasound in Medicine. 13(6). 487–489. 18 indexed citations
3.
Spellacy, W.N., et al.. (1991). Carbohydrate metabolic studies in women using a levonorgestrel/ethinyl estradiol containing triphasic oral contraceptive for eighteen months. International Journal of Gynecology & Obstetrics. 35(1). 69–71. 2 indexed citations
4.
Spellacy, W.N., et al.. (1990). Two-year carbohydrate metabolism studies in women using a norethindrone or levonorgestrel triphasic oral contraceptive. Advances in Contraception. 6(3). 185–191. 3 indexed citations
5.
Tsibris, John C.M., et al.. (1986). Cervicovaginal peroxidases: markers of the fertile period.. PubMed. 67(3). 316–20. 10 indexed citations
6.
Spellacy, W.N., W.C. Buhi, & S.A. Birk. (1977). The effects of a progesterone-t intrauterine device on carbohydrate and lipid metabolism in “normal” women: A three-month study. Contraception. 15(1). 65–73. 1 indexed citations
7.
Spellacy, W.N., W.C. Buhi, & S.A. Birk. (1976). The effects of norgestrel on carbohydrate and lipid metabolism over one year. American Journal of Obstetrics and Gynecology. 125(7). 984–986. 36 indexed citations
8.
Spellacy, W.N., et al.. (1976). The acute effects of Dramamine on uterine contractability during labor.. PubMed. 16(1). 27–8. 2 indexed citations
9.
Spellacy, W.N., W.C. Buhi, & S.A. Birk. (1974). Norgestrel and carbohydrate-lipid metabolism: Glucose, insulin and triglyceride changes during six months time of use. Contraception. 9(6). 615–625. 30 indexed citations
10.
Spellacy, W.N., et al.. (1974). Change in glucose and insulin after six months' treatment with the oral contraceptive Demulen. American Journal of Obstetrics and Gynecology. 119(2). 266–267. 2 indexed citations
11.
12.
Spellacy, W.N., et al.. (1971). Studies of Chlormadinone Acetate and Mestranol on Blood Glucose and Plasma Insulin. I. Six-Month Oral Glucose Tolerance Test. Fertility and Sterility. 22(4). 217–223. 10 indexed citations
13.
Singer, W. & W.N. Spellacy. (1970). HUMAN PLACENTAL LACTOGEN. The Lancet. 295(7640). 237–237. 4 indexed citations
14.
Spellacy, W.N., et al.. (1969). Human growth hormone levels during the menstrual cycle. American Journal of Obstetrics and Gynecology. 104(8). 1138–1142. 3 indexed citations
15.
Spellacy, W.N., et al.. (1968). Human growth hormone studies in patients with galactorrhea (Ahumada-del Castillo syndrome). American Journal of Obstetrics and Gynecology. 100(1). 84–89. 17 indexed citations
16.
Spellacy, W.N. & Karen L. Carlson. (1968). Pituitary-Function Studies Performed Before Treating Secondary Amenorrhea with Clomiphene Citrate. Fertility and Sterility. 19(5). 690–699. 3 indexed citations
17.
Spellacy, W.N., et al.. (1967). Menstrual cycle carbohydrate metabolism. American Journal of Obstetrics and Gynecology. 99(3). 382–386. 40 indexed citations
18.
Spellacy, W.N. & William Cohen. (1967). Clomiphene treatment of prolonged secondary amenorrhea associated with pituitary gonadotropin deficiency. American Journal of Obstetrics and Gynecology. 97(7). 943–948. 10 indexed citations
19.
Spellacy, W.N., Karen L. Carlson, & S.A. Birk. (1966). Human placental lactogen levels as a variable of placental weight and infant weight. American Journal of Obstetrics and Gynecology. 95(1). 118–119. 14 indexed citations
20.
Spellacy, W.N. & F. C. Goetz. (1963). INSULIN ANTIBODIES IN PREGNANCY. The Lancet. 282(7301). 222–224. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josef Zander Breakdown of academic impact, for papers by Badri N. Saxena Breakdown of academic impact, for papers by S.C. MacLeod Breakdown of academic impact, for papers by RodneyP. Shearman Breakdown of academic impact, for papers by Apichart Chittacharoen Breakdown of academic impact, for papers by M. Culliton Breakdown of academic impact, for papers by Leo Mäkäräinen Breakdown of academic impact, for papers by Ayşe Kafkaslı Breakdown of academic impact, for papers by Erdoğan Aslan Breakdown of academic impact, for papers by CN Wijeyaratne
Rankless by CCL
2026